DOXORUBICIN HYDROCHLORIDE LIPOSOME

DOXORUBICIN HYDROCHLORIDE · Sagent Pharmaceuticals

Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for DOXORUBICIN HYDROCHLORIDE LIPOSOME, covering 2007-05-17 to 2026-08-04. Get the full timeline:

Most recent: FDA Approved: DOXORUBICIN HYDROCHLORIDE LIPOSOME — Supplemental Application (Sagent Pharmaceuticals)